Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
PureTech Health PLC banner

PureTech Health PLC
F:0VQ

Watchlist Manager
PureTech Health PLC Logo
PureTech Health PLC
F:0VQ
Watchlist
Price: 1.4 EUR -3.45%
Market Cap: €385.2m
Write Note Create Alert Ask AI

Wall St Price Targets

0VQ Price Targets Summary
PureTech Health PLC

Wall Street analysts forecast 0VQ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0VQ is 4.43 EUR with a low forecast of 2.75 EUR and a high forecast of 6.05 EUR.

0VQ Lowest Forecast
2.75 EUR
96% Upside
0VQ Average Forecast
4.43 EUR
216% Upside
0VQ Highest Forecast
6.05 EUR
332% Upside
Lowest Forecast
Price Target
2.75 EUR
96% Upside
Average Forecast
Price Target
4.43 EUR
216% Upside
Highest Forecast
Price Target
6.05 EUR
332% Upside
PureTech Health PLC Competitors:
Price Targets
SMCP
SMCP SA
73% Upside
ZEAL
Zealand Pharma A/S
73% Upside
SSRM
SSR Mining Inc
61% Upside
MTLS
Materialise NV
58% Upside
SMCP
SMCP SA
73% Upside
ZEAL
Zealand Pharma A/S
73% Upside
SSRM
SSR Mining Inc
61% Upside
MTLS
Materialise NV
58% Upside

Revenue
Forecast

-5% / Year
Past Growth
65% / Year
Estimated Growth
Estimates Accuracy
38%
Average Beat
-5% / Year
Past Growth
65% / Year
Estimated Growth
Estimates Accuracy
38%
Average Beat

Over the last 11 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 4 years is 65%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss

What are analyst estimates?

Continue 0VQ Research

Summary
0VQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
0VQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0VQ stock valuation using valuation multiples.
Wall St Estimates
0VQ price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0VQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other PureTech Health PLC listings:
NASDAQ • USD
PRTC
 OTC • USD
PTCHF
 LSE • GBX
PRTC
 F • EUR
0VQ0
 OTC • USD
PRTCY
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0VQ's stock price target?
Price Target
4.43 EUR

According to Wall Street analysts, the average 1-year price target for 0VQ is 4.43 EUR with a low forecast of 2.75 EUR and a high forecast of 6.05 EUR.

What is the Revenue forecast for PureTech Health PLC?
Projected CAGR
65%

Over the last 11 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 4 years is 65%.

Back to Top
ALPHA SPREAD
Follow us
Join 349,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett